Studies on the effects of hydroxyurea and other anticancer drugs upon pyrimidine metabolism.
D000581:Amidohydrolases / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001201:Ascites / Q000201:enzymology; D002247:Carbon Isotopes; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003857:Deoxyuridine / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology*; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism; D007962:Leukocytes / Q000378:metabolism; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D009374:Neoplasms, Experimental / Q000201:enzymology; D009963:Orotic Acid / Q000378:metabolism; D011743:Pyrimidines / Q000096:biosynthesis / Q000378:metabolism*; D014166:Transferases / Q000378:metabolism; D014227:Triazines / Q000494:pharmacology
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D011743:Pyrimidines; D014227:Triazines; D003561:Cytarabine; D009963:Orotic Acid; D003520:Cyclophosphamide; D004247:DNA; D014166:Transferases; D000581:Amidohydrolases; D005472:Fluorouracil; D003857:Deoxyuridine; D006918:Hydroxyurea; D008727:Methotrexate